MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 3, 2005; DOI: 10.1124/mol.104.010223


0026-895X/05/6705-1629-1638$20.00
Mol Pharmacol 67:1629-1638, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.010223v1
mol.104.010223v2
67/5/1629    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Popowski, K.
Right arrow Articles by Kullak-Ublick, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popowski, K.
Right arrow Articles by Kullak-Ublick, G. A.
ORIGINAL ARTICLE

The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4{alpha} and Suppressed by Bile Acids

Katrin Popowski, Jyrki J. Eloranta, Michael Saborowski, Michael Fried, Peter J. Meier, and Gerd A. Kullak-Ublick

Laboratory of Molecular Gastroenterology and Hepatology (K.P., J.J.E., M.S., M.F., G.A.K.-U.) and Division of Clinical Pharmacology and Toxicology (P.J.M., G.A.K.-U.), University Hospital, Zurich, Switzerland

Abstract

The human organic anion transporter 2 (hOAT2, SLC22A7) mediates the sodium-independent uptake of numerous drugs, including cephalosporins, salicylates, dicarboxylates, and prostaglandins, and is mainly expressed in hepatocytes. Because the regulation of hOAT2 expression is poorly understood, we characterized cis-acting elements in the 5'-flanking region that regulate hOAT2 transcription. A consensus binding motif for the hepatocyte nuclear factor-4{alpha} (HNF-4{alpha}), arranged as a direct repeat (DR)-1, is located at nucleotides –329/-317 relative to the transcription initiation site. This element specifically binds HNF-4{alpha} in electrophoretic mobility shift assays. A luciferase-linked hOAT2 promoter fragment containing the HNF-4{alpha} binding site was transactivated upon cotransfection of an HNF-4{alpha} expression vector in Huh7 cells, whereas site-directed mutagenesis of the DR-1 element abolished activation by HNF-4{alpha}. Short interfering RNAs inhibiting endogenous HNF-4{alpha} expression markedly reduced endogenous expression of hOAT2 in Huh7 cells. Because HNF-4{alpha} is a known target for bile acid-mediated repression of gene transcription, we studied whether chenodeoxycholic acid (CDCA) suppresses hOAT2 gene expression by inhibiting HNF-4{alpha}-mediated transactivation. Treatment of Huh7 cells with CDCA or the synthetic farnesoid X receptor (FXR) agonist GW4064 decreased mRNA and protein levels and also nuclear binding activity of HNF-4{alpha}. The FXR-inducible transcriptional repressor small heterodimer partner inhibited transactivation of hOAT2 promoter constructs and of endogenous hOAT2 expression by HNF-4{alpha}. We conclude that the hOAT2 gene is critically dependent on HNF-4{alpha} and that bile acids repress the hOAT2 gene by inhibiting HNF-4{alpha}. Hepatic uptake of hOAT2 substrates may thus be decreased in disease conditions associated with elevated intracellular levels of bile acids.


Received December 13, 2004; accepted February 2, 2005

Address correspondence to: Dr. Gerd A. Kullak-Ublick, Department of Internal Medicine, University Hospital, CH-8091 Zurich, Switzerland. E-mail: gerd.kullak{at}usz.ch




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Aoki, T. Terada, M. Kajiwara, K. Ogasawara, I. Ikai, O. Ogawa, T. Katsura, and K.-i. Inui
Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F165 - F170.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Saji, R. Kikuchi, H. Kusuhara, I. Kim, F. J. Gonzalez, and Y. Sugiyama
Transcriptional Regulation of Human and Mouse Organic Anion Transporter 1 by Hepatocyte Nuclear Factor 1 {alpha}/{beta}
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 784 - 790.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. G. Dietrich, I. V. Martin, A. C. Porn, S. Voigt, C. Gartung, C. Trautwein, and A. Geier
Fasting induces basolateral uptake transporters of the SLC family in the liver via HNF4{alpha} and PGC1{alpha}
Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G585 - G590.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Ogasawara, T. Terada, J.-i. Asaka, T. Katsura, and K.-i. Inui
Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1819 - F1826.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-i. Asaka, T. Terada, K. Ogasawara, T. Katsura, and K.-i. Inui
Characterization of the Basal Promoter Element of Human Organic Cation Transporter 2 Gene
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 684 - 689.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
P Georgiev, A A Navarini, J J Eloranta, K S Lang, G A Kullak-Ublick, A Nocito, F Dahm, W Jochum, R Graf, and P-A Clavien
Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse
Gut, January 1, 2007; 56(1): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Hatzis, I. Kyrmizi, and I. Talianidis
Mitogen-Activated Protein Kinase-Mediated Disruption of Enhancer-Promoter Communication Inhibits Hepatocyte Nuclear Factor 4{alpha} Expression.
Mol. Cell. Biol., October 1, 2006; 26(19): 7017 - 7029.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Saborowski, G. A. Kullak-Ublick, and J. J. Eloranta
The Human Organic Cation Transporter-1 Gene Is Transactivated by Hepatocyte Nuclear Factor-4{alpha}
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 778 - 785.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics